+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nebulizers Market Report 2022

  • PDF Icon

    Report

  • 175 Pages
  • May 2022
  • Region: Global
  • The Business Research Company
  • ID: 5589747
Nebulizers Global Market Report 2022 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for nebulizers which play a critical role in the treatment of patients with COVID-19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the nebulizers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Nebulizers market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider nebulizers market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
  • The nebulizers market section of the report gives context. It compares the nebulizers market with other segments of the nebulizers market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, nebulizers indicators comparison

Scope


Markets Covered:

1) By Type: Pneumatic Nebulizer; Ultrasonic Nebulizer; Mesh Nebulizer
2) By Application: COPD; Cystic Fibrosis; Asthma; Other Applications
3) By End Use: Hospitals and Clinics; Emergency Centers; Home Healthcare
4) By Portability: Portable Nebulizer; Tabletop Nebulizer

Companies Mentioned: Agilent Technologies; Becton Dickinson and Company; Koninklijke Philips N.V.; Omron Corporation; Covidien plc.

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA and Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Nebulizers Market Characteristics3. Nebulizers Market Trends And Strategies4. Impact Of COVID-19 On Nebulizers
5. Nebulizers Market Size And Growth
5.1. Global Nebulizers Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Nebulizers Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Nebulizers Market Segmentation
6.1. Global Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pneumatic Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer
6.2. Global Nebulizers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • COPD
  • Cystic Fibrosis
  • Asthma
  • Other Applications
6.3. Global Nebulizers Market, Segmentation By End Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals and Clinics
  • Emergency Centers
  • Home Healthcare
6.4. Global Nebulizers Market, Segmentation By Portability, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Portable Nebulizer
  • Tabletop Nebulizer

7. Nebulizers Market Regional And Country Analysis
7.1. Global Nebulizers Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Nebulizers Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Nebulizers Market
8.1. Asia-Pacific Nebulizers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Nebulizers Market
9.1. China Nebulizers Market Overview
9.2. China Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Nebulizers Market
10.1. India Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Nebulizers Market
11.1. Japan Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Nebulizers Market
12.1. Australia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Nebulizers Market
13.1. Indonesia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Nebulizers Market
14.1. South Korea Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Nebulizers Market
15.1. Western Europe Nebulizers Market Overview
15.2. Western Europe Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Nebulizers Market
16.1. UK Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Nebulizers Market
17.1. Germany Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Nebulizers Market
18.3. France Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Nebulizers Market
19.1. Eastern Europe Nebulizers Market Overview
19.2. Eastern Europe Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Nebulizers Market
20.1. Russia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Nebulizers Market
21.1. North America Nebulizers Market Overview
21.2. North America Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Nebulizers Market
22.1. USA Nebulizers Market Overview
22.2. USA Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Nebulizers Market
23.1. South America Nebulizers Market Overview
23.2. South America Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Nebulizers Market
24.1. Brazil Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Nebulizers Market
25.1. Middle East Nebulizers Market Overview
25.2. Middle East Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Nebulizers Market
26.1. Africa Nebulizers Market Overview
26.2. Africa Nebulizers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Nebulizers Market Competitive Landscape And Company Profiles
27.1. Nebulizers Market Competitive Landscape
27.2. Nebulizers Market Company Profiles
27.2.1. Agilent Technologies
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Becton Dickinson and Company
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Koninklijke Philips N.V.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Omron Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Covidien plc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Nebulizers Market29. Nebulizers Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N.V, Omron Corporation, Covidien plc, GE Healthcare Ltd, Allied Healthcare Products Inc, Briggs Healthcare, PARI Pharma, and GF Health Products Inc.

The global nebulizer devices market is expected to grow from $0.99 billion in 2021 to $1.08 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The market is expected to grow to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%.

The nebulizer devices market consists of sales of nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis, and COPD.

The main types of nebulizer devices are pneumatic nebulizer, ultrasonic nebulizer, and mesh nebulizer. A pneumatic nebulizer converts the sample solution into an aerosol of tiny droplets using a jet of compressed gas. The flow of inert gas is carrying the droplets to an atomizer. The market is divided by portability into portable nebulizers and tabletop nebulizers. The various applications involved are COPD, cystic fibrosis, asthma, and others. The end-users are hospitals and clinics, emergency centers, and home healthcare.

North America was the largest region in the nebulizer devices market in 2021. Asia Pacific was the second largest region in the nebulizer devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The current Covid-19 pandemic has resulted in a surge in demand for nebulizers. There has been an increased use of albuterol inhalers in hospitals for Covid-19 and suspected Covid-19 patients to help with respiratory issues. This is mainly because respiratory viruses are the most common trigger for asthma exacerbations.

The rising geriatric population across the globe is expected to increase the usage of respiratory care devices including nebulizers over the forecast period. For instance, according to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million. As of 2019, 143 million people are aged 80 years or older. According to the United Nations, in 2020, the global population of a person aged 65 years and older was estimated to be 727 million and this number is projected to nearly double to over 1.5 billion in 2050. Elderly people are more susceptible to respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and the recent pandemic COVID-19 for many factors including the gradual decline of immune function. Therefore, a rise in the geriatric population is anticipated to propel the nebulizer market growth.

Nebulizer therapy requires a device that repeatedly and quickly delivers sufficient drug with minimal wastage, to the site of action. However, during nebulization aerosols with a smaller particle size are inhaled or delivered to the site of action while large particles return to the reservoir feeding tube. Also, some of the drug aerosols settle on the walls of the baffle. This drug is retained within the nebulizer, (also called residual drug or dead volume) or released into the environment during expiration. This results in drug wastage. Drug wastage during exhalation is therefore challenging the growth of the nebulizer market. The development of technically advanced novel nebulizers is however expected to reduce drug wastage and improve delivery efficacy.

The technologically advanced nebulizers including breath-enhanced, breath-actuated, and vibrating mesh nebulizers decrease the amount of drug lost during exhalation while increasing the efficiency of drug delivery and shaping the nebulizer devices market. For example, in June 2020, Respira Technologies, a health technology platform development company, revealed the introduction of a pharmaceutical-focused commercial development program for its RespiRx drug delivery system. Respirx is a compact, hand-holding vibrating mesh nebulizer built for local and systemic treatment and can work in any position placed by the patient. The latest and advanced nebulizers increase the output rate which in turn will decrease the administration time.

The countries covered in the nebulizer devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Agilent Technologies
  • Becton Dickinson and Company
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Covidien plc.
  • GE Healthcare Ltd.
  • Allied Healthcare Products, inc.
  • Briggs Healthcare
  • PARI Pharma
  • GF Health Products, Inc.
  • Medline Industries Inc.
  • Invacare Corporation

Methodology

Loading
LOADING...